0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ED Treatment Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-25A462
Home | Market Reports | Health| Pharmacy
Global ED Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global ED Treatment Market Research Report 2024

Code: QYRE-Auto-25A462
Report
January 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

ED Treatment Market Size

The global ED Treatment market was valued at US$ 4885 million in 2023 and is anticipated to reach US$ 7345.1 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.

ED Treatment Market

ED Treatment Market

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for ED Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ED Treatment.

Report Scope

The ED Treatment market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ED Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ED Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of ED Treatment Market Report

Report Metric Details
Report Name ED Treatment Market
Accounted market size in 2023 US$ 4885 million
Forecasted market size in 2030 US$ 7345.1 million
CAGR 6.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Sildenafil
  • Tadalafil
  • Others
Segment by Application
  • Hospitals
  • Drugstores
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of ED Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of ED Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is ED Treatment Market growing?

Ans: The ED Treatment Market witnessing a CAGR of 6.0% during the forecast period 2024-2030.

What is the ED Treatment Market size in 2030?

Ans: The ED Treatment Market size in 2030 will be US$ 7345.1 million.

Who are the main players in the ED Treatment Market report?

Ans: The main players in the ED Treatment Market are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO.

What are the Application segmentation covered in the ED Treatment Market report?

Ans: The Applications covered in the ED Treatment Market report are Hospitals, Drugstores, Other

What are the Type segmentation covered in the ED Treatment Market report?

Ans: The Types covered in the ED Treatment Market report are Sildenafil, Tadalafil, Others

1 ED Treatment Market Overview
1.1 Product Overview and Scope of ED Treatment
1.2 ED Treatment Segment by Type
1.2.1 Global ED Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 ED Treatment Segment by Application
1.3.1 Global ED Treatment Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Global ED Treatment Market Size Estimates and Forecasts
1.4.1 Global ED Treatment Revenue 2019-2030
1.4.2 Global ED Treatment Sales 2019-2030
1.4.3 Global ED Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 ED Treatment Market Competition by Manufacturers
2.1 Global ED Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global ED Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global ED Treatment Average Price by Manufacturers (2019-2024)
2.4 Global ED Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ED Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ED Treatment, Product Type & Application
2.7 ED Treatment Market Competitive Situation and Trends
2.7.1 ED Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest ED Treatment Players Market Share by Revenue
2.7.3 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ED Treatment Retrospective Market Scenario by Region
3.1 Global ED Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global ED Treatment Global ED Treatment Sales by Region: 2019-2030
3.2.1 Global ED Treatment Sales by Region: 2019-2024
3.2.2 Global ED Treatment Sales by Region: 2025-2030
3.3 Global ED Treatment Global ED Treatment Revenue by Region: 2019-2030
3.3.1 Global ED Treatment Revenue by Region: 2019-2024
3.3.2 Global ED Treatment Revenue by Region: 2025-2030
3.4 North America ED Treatment Market Facts & Figures by Country
3.4.1 North America ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America ED Treatment Sales by Country (2019-2030)
3.4.3 North America ED Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe ED Treatment Market Facts & Figures by Country
3.5.1 Europe ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe ED Treatment Sales by Country (2019-2030)
3.5.3 Europe ED Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ED Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific ED Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific ED Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America ED Treatment Market Facts & Figures by Country
3.7.1 Latin America ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America ED Treatment Sales by Country (2019-2030)
3.7.3 Latin America ED Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa ED Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa ED Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa ED Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global ED Treatment Sales by Type (2019-2030)
4.1.1 Global ED Treatment Sales by Type (2019-2024)
4.1.2 Global ED Treatment Sales by Type (2025-2030)
4.1.3 Global ED Treatment Sales Market Share by Type (2019-2030)
4.2 Global ED Treatment Revenue by Type (2019-2030)
4.2.1 Global ED Treatment Revenue by Type (2019-2024)
4.2.2 Global ED Treatment Revenue by Type (2025-2030)
4.2.3 Global ED Treatment Revenue Market Share by Type (2019-2030)
4.3 Global ED Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global ED Treatment Sales by Application (2019-2030)
5.1.1 Global ED Treatment Sales by Application (2019-2024)
5.1.2 Global ED Treatment Sales by Application (2025-2030)
5.1.3 Global ED Treatment Sales Market Share by Application (2019-2030)
5.2 Global ED Treatment Revenue by Application (2019-2030)
5.2.1 Global ED Treatment Revenue by Application (2019-2024)
5.2.2 Global ED Treatment Revenue by Application (2025-2030)
5.2.3 Global ED Treatment Revenue Market Share by Application (2019-2030)
5.3 Global ED Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly ED Treatment Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer ED Treatment Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer ED Treatment Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Corporation Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BaiYunShan General Factory ED Treatment Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Corporation Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 S.K. Chemicals ED Treatment Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Corporation Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharma ED Treatment Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dong-A ST ED Treatment Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Corporation Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Metuchen Pharma ED Treatment Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Corporation Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Seoul Pharma ED Treatment Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Corporation Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CSBIO. ED Treatment Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ED Treatment Industry Chain Analysis
7.2 ED Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ED Treatment Production Mode & Process
7.4 ED Treatment Sales and Marketing
7.4.1 ED Treatment Sales Channels
7.4.2 ED Treatment Distributors
7.5 ED Treatment Customers
8 ED Treatment Market Dynamics
8.1 ED Treatment Industry Trends
8.2 ED Treatment Market Drivers
8.3 ED Treatment Market Challenges
8.4 ED Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global ED Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global ED Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global ED Treatment Market Competitive Situation by Manufacturers in 2023
    Table 4. Global ED Treatment Sales (Units) of Key Manufacturers (2019-2024)
    Table 5. Global ED Treatment Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global ED Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global ED Treatment Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market ED Treatment Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of ED Treatment, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of ED Treatment, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of ED Treatment, Product Type & Application
    Table 12. Global Key Manufacturers of ED Treatment, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global ED Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ED Treatment as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global ED Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global ED Treatment Sales by Region (2019-2024) & (Units)
    Table 18. Global ED Treatment Sales Market Share by Region (2019-2024)
    Table 19. Global ED Treatment Sales by Region (2025-2030) & (Units)
    Table 20. Global ED Treatment Sales Market Share by Region (2025-2030)
    Table 21. Global ED Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global ED Treatment Revenue Market Share by Region (2019-2024)
    Table 23. Global ED Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global ED Treatment Revenue Market Share by Region (2025-2030)
    Table 25. North America ED Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America ED Treatment Sales by Country (2019-2024) & (Units)
    Table 27. North America ED Treatment Sales by Country (2025-2030) & (Units)
    Table 28. North America ED Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America ED Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe ED Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe ED Treatment Sales by Country (2019-2024) & (Units)
    Table 32. Europe ED Treatment Sales by Country (2025-2030) & (Units)
    Table 33. Europe ED Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe ED Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific ED Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific ED Treatment Sales by Region (2019-2024) & (Units)
    Table 37. Asia Pacific ED Treatment Sales by Region (2025-2030) & (Units)
    Table 38. Asia Pacific ED Treatment Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific ED Treatment Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America ED Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America ED Treatment Sales by Country (2019-2024) & (Units)
    Table 42. Latin America ED Treatment Sales by Country (2025-2030) & (Units)
    Table 43. Latin America ED Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America ED Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa ED Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa ED Treatment Sales by Country (2019-2024) & (Units)
    Table 47. Middle East & Africa ED Treatment Sales by Country (2025-2030) & (Units)
    Table 48. Middle East & Africa ED Treatment Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa ED Treatment Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global ED Treatment Sales (Units) by Type (2019-2024)
    Table 51. Global ED Treatment Sales (Units) by Type (2025-2030)
    Table 52. Global ED Treatment Sales Market Share by Type (2019-2024)
    Table 53. Global ED Treatment Sales Market Share by Type (2025-2030)
    Table 54. Global ED Treatment Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global ED Treatment Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global ED Treatment Revenue Market Share by Type (2019-2024)
    Table 57. Global ED Treatment Revenue Market Share by Type (2025-2030)
    Table 58. Global ED Treatment Price (USD/Unit) by Type (2019-2024)
    Table 59. Global ED Treatment Price (USD/Unit) by Type (2025-2030)
    Table 60. Global ED Treatment Sales (Units) by Application (2019-2024)
    Table 61. Global ED Treatment Sales (Units) by Application (2025-2030)
    Table 62. Global ED Treatment Sales Market Share by Application (2019-2024)
    Table 63. Global ED Treatment Sales Market Share by Application (2025-2030)
    Table 64. Global ED Treatment Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global ED Treatment Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global ED Treatment Revenue Market Share by Application (2019-2024)
    Table 67. Global ED Treatment Revenue Market Share by Application (2025-2030)
    Table 68. Global ED Treatment Price (USD/Unit) by Application (2019-2024)
    Table 69. Global ED Treatment Price (USD/Unit) by Application (2025-2030)
    Table 70. Eli Lilly Corporation Information
    Table 71. Eli Lilly Description and Business Overview
    Table 72. Eli Lilly ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Eli Lilly ED Treatment Product
    Table 74. Eli Lilly Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Pfizer ED Treatment Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Bayer Corporation Information
    Table 81. Bayer Description and Business Overview
    Table 82. Bayer ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Bayer ED Treatment Product
    Table 84. Bayer Recent Developments/Updates
    Table 85. BaiYunShan General Factory Corporation Information
    Table 86. BaiYunShan General Factory Description and Business Overview
    Table 87. BaiYunShan General Factory ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. BaiYunShan General Factory ED Treatment Product
    Table 89. BaiYunShan General Factory Recent Developments/Updates
    Table 90. S.K. Chemicals Corporation Information
    Table 91. S.K. Chemicals Description and Business Overview
    Table 92. S.K. Chemicals ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. S.K. Chemicals ED Treatment Product
    Table 94. S.K. Chemicals Recent Developments/Updates
    Table 95. Teva Pharma Corporation Information
    Table 96. Teva Pharma Description and Business Overview
    Table 97. Teva Pharma ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Teva Pharma ED Treatment Product
    Table 99. Teva Pharma Recent Developments/Updates
    Table 100. Dong-A ST Corporation Information
    Table 101. Dong-A ST Description and Business Overview
    Table 102. Dong-A ST ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Dong-A ST ED Treatment Product
    Table 104. Dong-A ST Recent Developments/Updates
    Table 105. Metuchen Pharma Corporation Information
    Table 106. Metuchen Pharma Description and Business Overview
    Table 107. Metuchen Pharma ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Metuchen Pharma ED Treatment Product
    Table 109. Metuchen Pharma Recent Developments/Updates
    Table 110. Seoul Pharma Corporation Information
    Table 111. Seoul Pharma Description and Business Overview
    Table 112. Seoul Pharma ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Seoul Pharma ED Treatment Product
    Table 114. Seoul Pharma Recent Developments/Updates
    Table 115. CSBIO. Corporation Information
    Table 116. CSBIO. Description and Business Overview
    Table 117. CSBIO. ED Treatment Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. CSBIO. ED Treatment Product
    Table 119. CSBIO. Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. ED Treatment Distributors List
    Table 123. ED Treatment Customers List
    Table 124. ED Treatment Market Trends
    Table 125. ED Treatment Market Drivers
    Table 126. ED Treatment Market Challenges
    Table 127. ED Treatment Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of ED Treatment
    Figure 2. Global ED Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global ED Treatment Market Share by Type in 2023 & 2030
    Figure 4. Sildenafil Product Picture
    Figure 5. Tadalafil Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global ED Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global ED Treatment Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Drugstores
    Figure 11. Other
    Figure 12. Global ED Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global ED Treatment Market Size (2019-2030) & (US$ Million)
    Figure 14. Global ED Treatment Sales (2019-2030) & (Units)
    Figure 15. Global ED Treatment Average Price (USD/Unit) & (2019-2030)
    Figure 16. ED Treatment Report Years Considered
    Figure 17. ED Treatment Sales Share by Manufacturers in 2023
    Figure 18. Global ED Treatment Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest ED Treatment Players: Market Share by Revenue in 2023
    Figure 20. ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global ED Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America ED Treatment Sales Market Share by Country (2019-2030)
    Figure 23. North America ED Treatment Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe ED Treatment Sales Market Share by Country (2019-2030)
    Figure 27. Europe ED Treatment Revenue Market Share by Country (2019-2030)
    Figure 28. Germany ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific ED Treatment Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific ED Treatment Revenue Market Share by Region (2019-2030)
    Figure 35. China ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America ED Treatment Sales Market Share by Country (2019-2030)
    Figure 46. Latin America ED Treatment Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa ED Treatment Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa ED Treatment Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E ED Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of ED Treatment by Type (2019-2030)
    Figure 56. Global Revenue Market Share of ED Treatment by Type (2019-2030)
    Figure 57. Global ED Treatment Price (USD/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of ED Treatment by Application (2019-2030)
    Figure 59. Global Revenue Market Share of ED Treatment by Application (2019-2030)
    Figure 60. Global ED Treatment Price (USD/Unit) by Application (2019-2030)
    Figure 61. ED Treatment Value Chain
    Figure 62. ED Treatment Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS